Spots Global Cancer Trial Database for breast carcinoma
Every month we try and update this database with for breast carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy | NCT03135782 | Breast Carcinom... Caregiver Head and Neck C... Lung Carcinoma Prostate Carcin... Tobacco Use | Communication S... Medical Chart R... Questionnaire A... Tobacco Cessati... | - | OHSU Knight Cancer Institute | |
| HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics | NCT04905082 | Breast Carcinom... Colorectal Carc... Lung Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Best Practice Educational Int... Educational Int... Genomic Profile Survey Administ... | 18 Years - | City of Hope Medical Center | |
| Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS) | NCT06055881 | Breast Carcinom... | Non-Interventio... | 18 Years - | Mayo Clinic | |
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | NCT04955808 | Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin... | Biospecimen Col... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS) | NCT06055881 | Breast Carcinom... | Non-Interventio... | 18 Years - | Mayo Clinic | |
| Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer | NCT05132296 | Breast Carcinom... | Behavioral Inte... Best Practice FitBit Nutrition Educa... Physical Activi... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer | NCT03176979 | Breast Carcinom... | Contrast Agent Digital Tomosyn... Dual-Energy Con... | 18 Years - | University of Southern California | |
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC | NCT05191004 | Advanced Breast... Metastatic Brea... Breast Cancer Breast Carcinom... Cancer of the B... Cancer of Breas... Malignant Tumor... Breast Tumor | NUV-422 Fulvestrant | 18 Years - | Nuvation Bio Inc. | |
| An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study) | NCT05263362 | Breast Fibrosis Breast Cancer Breast Cancer F... Breast Neoplasm... Breast Carcinom... Breast Carcinom... | no intervention | 18 Years - | Erasmus Medical Center | |
| Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study | NCT05703399 | Breast Carcinom... | Biospecimen Col... Questionnaire A... | - | Mayo Clinic | |
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction | NCT06195306 | Breast Atypical... Breast Carcinom... Breast Ductal C... Breast Lobular ... | Biospecimen Col... Mammography Omega-3-Acid Et... Questionnaire A... Random Periareo... Tamoxifen | 45 Years - 65 Years | National Cancer Institute (NCI) | |
| A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer | NCT06188559 | Breast Cancer | BB-1701 | 18 Years - | Eisai Inc. | |
| A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer | NCT05584644 | Breast Cancer Breast Carcinom... Breast Neoplasm... Breast Tumors Cancer of Breas... | Palbociclib plu... Palbociclib plu... | 18 Years - 99 Years | Pfizer | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study | NCT00553358 | Neoplasms, Brea... | Lapatinib Trastuzumab Paclitaxel | 18 Years - | Novartis | |
| Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer | NCT03310957 | Triple Negative... | ladiratuzumab v... Pembrolizumab | 18 Years - | Seagen Inc. | |
| EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer | NCT05086705 | Breast Carcinom... Breast Ductal C... Breast Lobular ... Hot Flashes | EMBr Wave Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer | NCT00179348 | Alopecia Anxiety Breast Carcinom... Cognitive Side ... Colorectal Carc... Depression Fatigue Lung Carcinoma Nausea and Vomi... Pain Psychological I... Sleep Disorder Weight Change | Quality-of-Life... Yoga | 18 Years - | Albert Einstein College of Medicine | |
| A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer | NCT02296801 | Breast Cancer Breast Carcinom... Breast Tumors | Letrozole palbociclib | 18 Years - | NSABP Foundation Inc | |
| Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients | NCT04262518 | Breast Cancer Invasive Breast... Metastatic Brea... Breast Carcinom... Metastatic Brea... | Outcomes4Me Mob... | 18 Years - | Outcomes4Me | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects | NCT03897270 | Breast Carcinom... Healthy Subject | Photoacoustic I... | 18 Years - | Roswell Park Cancer Institute | |
| Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study | NCT02861859 | Breast Cancer | Olanzapine Olanzapine Plac... | 18 Years - | Ottawa Hospital Research Institute | |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | NCT05364450 | Breast Neoplasm Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear | Enhanced Usual ... Acceptance Comm... Cognitive Behav... | 18 Years - 99 Years | Indiana University | |
| Cancer Genetic Testing in Ethnic Populations | NCT04475640 | Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma | Biospecimen Col... Genetic Testing | 18 Years - | Mayo Clinic | |
| Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy | NCT04989504 | Breast Carcinom... Mastectomy Pati... | Best Practice Wound Dressing ... Quality-of-Life... Questionnaire A... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery | NCT05558917 | Breast Cancer Breast Neoplasm... Breast Carcinom... | PECS BLOCK 2 ESP BLOCK | 18 Years - | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | |
| Delphinus SoftVue Prospective Case Collection - ARM 1 | NCT03257839 | Breast Neoplasm... | Routine Full-Fi... Routine Digital... Automated Whole... | 18 Years - | Delphinus Medical Technologies, Inc. | |
| Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors | NCT02521961 | Breast Carcinom... Cancer Survivor | Informational I... Informational I... Quality-of-Life... Questionnaire A... Support Group T... | 18 Years - | Fred Hutchinson Cancer Center | |
| Magnetic Resonance Imaging in Patients With Breast Cancer | NCT00610181 | Breast Cancer | MRI | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer | NCT03583944 | Breast Neoplasm... | Eribulin Mesyla... | 18 Years - | Eisai Inc. | |
| Ultrasound Imaging Technique in Detecting Breast Microcalcifications in Patients Undergoing Biopsy for a Breast Abnormality | NCT03031561 | Breast Carcinom... Microcalcificat... | Ultrasound MicoPure ultras... Biopsy of Breas... | 18 Years - | Thomas Jefferson University | |
| Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery | NCT03113825 | Primary Invasiv... Carcinoma Breas... Breast Cancer F... Carcinoma, Duct... Stage II Breast... Stage I Breast ... Stage III Breas... | Investigational... AVB-620 | 18 Years - | Avelas Biosciences, Inc. | |
| Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion | NCT05036083 | Breast Carcinom... Invasive Breast... | Contrast-Enhanc... Digital Tomosyn... Electronic Heal... Iodinated Contr... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients. | NCT06202118 | Breast Cancer Recurrent Breas... Breast Carcinom... | Diffusing Alpha... | 65 Years - 120 Years | Alpha Tau Medical LTD. | |
| Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases | NCT03970967 | Breast Carcinom... Metastatic Brea... Invasive Breast... Distant Metasta... | Device: Radiati... | 45 Years - | Alpha Tau Medical LTD. | |
| Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment | NCT05005936 | Breast Carcinom... | Ultrasonography Ultrasonography | 18 Years - | M.D. Anderson Cancer Center | |
| Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients | NCT03650894 | Breast Neoplasm... Breast Cancer Breast Carcinom... Breast Tumor | Nivolumab Ipilimumab Bicalutamide | 18 Years - | Providence Health & Services | |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | NCT04902144 | Breast Carcinom... Colon Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Electronic Heal... Questionnaire A... Behavioral Inte... | 19 Years - 90 Years | Fred Hutchinson Cancer Center | |
| Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer | NCT02610426 | Breast Carcinom... | Laboratory Biom... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer | NCT00001239 | Breast Cancer Breast Neoplasm... | FLAC with GM-CS... | - | National Institutes of Health Clinical Center (CC) | |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
| 3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer | NCT05704283 | Breast Carcinom... | Ultrasound Imag... | 18 Years - | Mayo Clinic | |
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members | NCT02194387 | Body Mass Index... BRCA1 Gene Muta... BRCA2 Gene Muta... Breast Carcinom... Cancer Survivor Chronic Lymphoc... Fatigue Health Status U... Lynch Syndrome Ovarian Carcino... Overweight | Dietary Interve... Dietary Interve... Internet-Based ... Internet-Based ... Laboratory Biom... Questionnaire A... Telephone-Based... Telephone-Based... | 18 Years - | M.D. Anderson Cancer Center | |
| Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer | NCT02810873 | Breast Carcinom... | Positron Emissi... Positron Emissi... Fludeoxyglucose... Copper Cu 64 TP... | 18 Years - | Thomas Jefferson University | |
| An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer | NCT04871139 | Breast Carcinom... | Biopsy Contrast-Enhanc... Questionnaire A... Radioactive Iod... | 25 Years - 85 Years | M.D. Anderson Cancer Center | |
| Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis | NCT06137651 | Breast Carcinom... Metastatic Mali... Metastatic Mali... | Biospecimen Col... Computed Tomogr... Magnetic Resona... Radiation Thera... Resection Trotabresib Vinorelbine | 18 Years - | Northwestern University | |
| Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms | NCT01641068 | Breast Carcinom... Cancer Survivor Cognitive Side ... Malignant Femal... | Cognitive Inter... Educational Int... Functional Magn... Memory Interven... Quality-of-Life... Questionnaire A... | 21 Years - 90 Years | University of Washington | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Cryotherapy for Breast Cancer Trial | NCT01671943 | Breast Carcinom... | Ice-Sense3TM | - | IceCure Medical Ltd. | |
| Intelligent Remote Intervention for High-risk Breast Cancer Populations | NCT06193707 | Ultrasonography Breast Neoplasm... Breast Carcinom... Health Educatio... | the Remote Inte... the Traditional... | 18 Years - 60 Years | Qianfoshan Hospital | |
| Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer | NCT04913064 | Breast Carcinom... | Questionnaire A... White Button Mu... | 21 Years - | City of Hope Medical Center | |
| Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy | NCT00887692 | Breast Carcinom... | prone and supin... | 18 Years - | University Hospital, Ghent | |
| Evaluation of Ocoxin®-Viusid® in Breast Cancer | NCT03576521 | Breast Cancer Breast Carcinom... Adriamycin Toxi... Cyclosporine To... | CT + Ocoxin-Viu... CT + Placebo | 18 Years - | Catalysis SL | |
| Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer | NCT00073528 | Breast Neoplasm... | Lapatinib Letrozole Placebo | 18 Years - | Novartis | |
| A Patient Navigation Program for Addressing Disparities in Breast Cancer Care | NCT06350500 | Breast Carcinom... Breast Ductal C... | Patient Navigat... Questionnaire | 18 Years - | Roswell Park Cancer Institute | |
| Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery | NCT00645138 | Breast Cancer | Paravertebral B... General Anesthe... | 18 Years - | Weill Medical College of Cornell University | |
| Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | NCT03408561 | Breast Carcinom... Colon Carcinoma Kidney Carcinom... Lymphoma Non-Small Cell ... Prostate Carcin... | Internet-Based ... Survey Administ... | - | University of Southern California | |
| A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis | NCT06336928 | Breast Carcinom... | Non-Interventio... | 18 Years - | University of Southern California | |
| Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants | NCT05978128 | Breast Carcinom... Lung Carcinoma | Health Educatio... Health Promotio... Patient Navigat... Survey Administ... | 40 Years - 80 Years | Jonsson Comprehensive Cancer Center | |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | NCT05364450 | Breast Neoplasm Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear | Enhanced Usual ... Acceptance Comm... Cognitive Behav... | 18 Years - 99 Years | Indiana University | |
| Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer | NCT05012813 | Breast Carcinom... Prostate Carcin... | Aromatherapy wi... | 18 Years - | OHSU Knight Cancer Institute | |
| Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer | NCT03941743 | Breast Carcinom... | Fingolimod Fingolimod Hydr... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy | NCT04989504 | Breast Carcinom... Mastectomy Pati... | Best Practice Wound Dressing ... Quality-of-Life... Questionnaire A... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults | NCT05021172 | Breast Carcinom... Colorectal Carc... | Best Practice Informational I... Questionnaire A... Survey Administ... | 70 Years - | University of California, San Francisco | |
| Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer | NCT05325151 | Breast Carcinom... | Educational Int... Genetic Counsel... Survey Administ... | 30 Years - 64 Years | Ohio State University Comprehensive Cancer Center | |
| MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer | NCT06090630 | Benign Breast N... Breast Carcinom... Malignant Breas... | Diffusion Weigh... Magnetic Resona... | 18 Years - 80 Years | Jonsson Comprehensive Cancer Center | |
| CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers | NCT02355262 | Breast Carcinom... Cervical Carcin... Colorectal Carc... Health Status U... Human Papilloma... Malignant Neopl... | Informational I... | 18 Years - | OHSU Knight Cancer Institute | |
| A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer | NCT04588298 | HER2-negative B... | AZD9833 | 18 Years - 130 Years | AstraZeneca | |
| Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer | NCT02610413 | Breast Carcinom... | Laboratory Biom... | - | National Cancer Institute (NCI) | |
| Breast Cancer Survivor Educational Intervention | NCT05700396 | Breast Cancer Breast Neoplasm... Breast Carcinom... Breast Cancer F... | Breast Cancer S... | 22 Years - | Massachusetts General Hospital | |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | NCT06268665 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Invasive Breast... Ovarian Cancer Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Breast Cancer S... Breast Cancer I... Breast Cancer, ... Breast Cancer, ... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cancer, Breast Tumors, Breast Mammary Cancer Mammary Carcino... Breast Carcinom... Breast Neoplasm Malignant Breas... Malignant Tumor... Cancer of Ovary Ovary Cancer Ovary Neoplasm | Tart Cherry Jui... | 18 Years - | University of California, Davis | |
| Mobile Health for Adherence in Breast Cancer Patients | NCT06112613 | Anatomic Stage ... Breast Carcinom... HER2-Negative B... Hormone Recepto... | Electronic Heal... Health Promotio... Health Telemoni... Interview Patient Navigat... Survey Administ... Text Message-Ba... | 18 Years - | Eastern Cooperative Oncology Group | |
| Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel | NCT02297412 | Acute Pain Breast Carcinom... Peripheral Neur... | Minocycline Hyd... Placebo Quality-of-Life... Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer | NCT03583944 | Breast Neoplasm... | Eribulin Mesyla... | 18 Years - | Eisai Inc. | |
| INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy | NCT06246084 | Breast Cancer Breast Cancer F... Breast Carcinom... | Endocrine Thera... | 18 Years - | Dana-Farber Cancer Institute | |
| Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD | NCT01655004 | Breast Carcinom... | Exemestane | 21 Years - 99 Years | National University Hospital, Singapore | |
| Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer | NCT06130826 | Breast Carcinom... Colorectal Carc... | Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Immunotherapy Magnetic Resona... Positron Emissi... Stereotactic Bo... | 18 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
